The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trialRandomized Controlled Trial Published on 2022-05-012022-10-05 Journal: Complementary therapies in medicine [Category] COVID19(2023년), SARS, 임상, [키워드] Affect Arm assigned baseline Biomarker C-reactive protein test chain changes in Characteristics chill Clinical outcome Clinical sign Clinical symptoms clinical variable control arm Controlled trial cough COVID-19 COVID-19 patients CRP levels CT scans demographics diagnostic double-blind Effect eight evaluate the effect evaluated Fever hospital increase in Intervention intervention arm Laboratory LOS lung involvement marker myalgia not significant not significantly different organic oxygen saturation Patient Phyllanthus Phyllanthus Emblica Phyllanthus Emblica. Randomized Randomly RCT reaction reduction in respiratory rate RT-PCR severity Shortness of breath significantly significantly shorter sore throat SpO2 study group Symptom the mean therapy two group variable variables weakness were assessed [DOI] 10.1016/j.ctim.2022.102808 PMC 바로가기 [Article Type] Randomized Controlled Trial
Clinical Presentation and Outcome of Hospitalized Patients With COVID-19 in the First and Second Waves in Saudi Arabia사우디 아라비아의 1차 및 2차 유행에서 COVID-19로 입원한 환자의 임상 발표 및 결과Article Published on 2022-05-012022-09-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] age ALT Antibiotics antiviral therapy case sery Characteristics clinical Clinical characteristics Clinical data COVID-19 death death rate distress epidemiological First wave hospitalized patient hospitalized patients Laboratory lymphocyte Lymphocytes mean value myalgia Occurrence outcome Patient Platelet platelet counts presentation receive respiratory distress retrospective SARS-CoV-2 Saudi Arabia second second wave Shortness of breath significantly significantly more sore sore throat Symptoms tachypnea the SARS-CoV-2 variants Wave Waves [DOI] 10.1016/j.ijid.2022.02.048 PMC 바로가기 [Article Type] Article
Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trialResearch article Published on 2022-05-012022-10-05 Journal: Journal of trace elements in medicine and biology [Category] 임상, [키워드] biochemical parameter Boron Boron citrate clinical trial Combination Concentration concentrations cough COVID-19 COVID-19 patients diagnosis of COVID-19 double-blind erythrocyte sedimentation rate fatigue four group group groups hemoglobin High-sensitivity C-reactive protein IMPROVE interleukin-1β Lymphocyte count medications myalgia O2 Saturation Oleoylethanolamide Patient patients with COVID-19 Placebo Platelet post-intervention PPAR-α Randomized recruited reduction in respiratory rate Result SARS-CoV-2 serum interleukin-6 levels serum lactate Shortness of breath significant decrease significant difference significant increases in significantly symptoms of COVID-19 therapeutic effect Therapies Treatment were assessed White blood cell [DOI] 10.1016/j.jtemb.2022.126945 [Article Type] Research article
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines불활성화 백신 2회 투여 후 성인에서 AZD1222의 저용량 대 표준 용량의 추가 용량에 대한 무작위 임상 시험Randomized Controlled Trial Published on 2022-04-202022-09-11 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, [키워드] 95% CI Adults anti-S anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG. Anti-spike antibody Antibody titer ARMS AstraZeneca AZD1222 baseline booster booster dose ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine completion conducted CoronaVac CoronaVac vaccine delta variant dose double-blinded enrolled evaluate Fever geometric geometric mean geometric mean ratio Geometric means GMR GMRs healthy IgG immunogenicity inactivated Inactivated vaccine Infection IQR low dose low-dose median age median interval myalgia neutralization test neutralizing antibody Neutralizing antibody titer participant Prevent Randomized randomized clinical trial randomized, controlled trial RBD IgG reactogenicity receive recipient S-RBD SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine significantly lower Standard dose surrogate surrogate virus neutralization test sVNT systemic reactogenicity the SARS-CoV-2 variant Viral Viral particles virus neutralization test wild type [DOI] 10.1016/j.vaccine.2022.03.036 PMC 바로가기 [Article Type] Randomized Controlled Trial
An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients경증 및 중등도 입원 코비드-19 환자를 위한 인도메타신의 공개 라벨 무작위 임상 시험Randomized Controlled Trial Published on 2022-04-192022-09-12 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 신약개발, 임상, 진단, 치료법, 치료제, [키워드] addition adjuvant therapies Admission adverse event afebrile anti-inflammatory drug Antiviral Arm ARMS Block randomisation blood chemistry clinical trial control arm coronavirus disease cough COVID-19 COVID-19 patient Desaturation discharge effective Efficacy and safety evaluated Fever Follow-up High-flow oxygen hospital hospitalised indomethacin Ivermectin medication Mild moderate myalgia open label Paracetamol parameters Patient patients primary endpoint profile provided randomised randomized clinical trial reported required retained Safe Secondary endpoints Standard of care Symptom symptomatic tiredness [DOI] 10.1038/s41598-022-10370-1 PMC 바로가기 [Article Type] Randomized Controlled Trial
Role of serology tests in COVID-19 non-hospitalized patients: A cross-sectional studyCOVID-19 입원하지 않은 환자에서 혈청 검사의 역할: 단면 연구Article Published on 2022-04-142022-09-12 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome Analysis antibody Antibody titer Assessing association Asymptomatic can be used catastrophic characteristics of patient chills chronic disease clinical conducted Contact coronavirus cough Course COVID-19 COVID-19 patient cross-sectional disease Dyspnea epidemiological fatigue feature Fever GI symptom IgG IgG and IgM IgG level IgG test IgM IgM and IgG IgM test Infection investigated Iran Mild myalgia Nasopharyngeal swab Outpatient p value Patient patients PCR PCRs positive positive PCR positive PCR test role SARS-CoV-2 SARS-CoV2 serologic test serology serology test significantly specimen Symptom Tehran tested underlying disease [DOI] 10.1371/journal.pone.0266923 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers의료 종사자에서 비활성화된 COVID-19 백신의 안전성 및 면역원성Article Published on 2022-04-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료법, [키워드] administration adverse event Adverse reaction Adverse reactions age antibodies antibody Antibody Response Antibody responses appear booster doses comparable Concentration conducted convalescent plasma convalescent serum CoronaVac coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine domain dose Effective vaccines geometric mean geometric mean concentration GMC Health care Health care worker health care workers hospital IgG immunization immunogenicity Immunoglobulin Immunoglobulin G inactivated Inactivated vaccine incidence Infection injection Injection-site pain Local myalgia N protein nucleocapsid nucleocapsid protein Pain pandemic participant positive prospective cohort study Protein RBD Receptor-binding domain recruited regimen Safe Safety SARS-CoV-2 Serious Adverse Event Serious Adverse Events seroconversion rate seroconversion rates Spike protein tested the RBD Total total antibodies total antibody U/mL Vaccine virus waned [DOI] 10.1002/jmv.27458 PMC 바로가기 [Article Type] Article
Inflawell ® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trialInflawell®은 무작위 이중 맹검 위약 대조 임상 시험에서 중등도 COVID-19 환자의 호중구 대 림프구 비율을 개선하고 입원 기간을 단축합니다.Randomized Controlled Trial Published on 2022-04-012022-09-11 Journal: Inflammopharmacology [Category] COVID19(2023년), SARS, 임상, 치료기술, [키워드] activated activities addition administration Anti-inflammatory Anti-viral drugs average baseline Boswellia boswellic acids clinical clinical symptom Clinical symptoms clinical trial completion conducted cough COVID-19 COVID-19 symptom COVID-19 symptoms CRP Cytokines Disease progression double-blind duration of hospitalization dysfunction Dyspnea dysregulated immune response enrolled evaluated Fewer patients Gustatory headache help Hospital stay Hospitalization hospitalized patient IMPROVE increase in Inflammation Inflawell® syrup Intervention investigated LDH lymphocyte Lymphocytes marker Moderate COVID-19 moderate COVID-19 patients myalgia neutrophil Neutrophil-to-lymphocyte ratio Neutrophils NLR NLR. olfactory olfactory and gustatory dysfunction oxygen oxygen saturation Patient patients with moderate PCR-positive Placebo placebo group placebo-controlled placebo-controlled clinical trial Prevent prevent disease progression pro-inflammatory cytokines public health Randomized reduce Registered significant decrease significant increase significantly shorter Standard of care statistically significant Symptom syrup the placebo group the WHO therapeutic potential TNF Treatment Trial unique Vaccine [DOI] 10.1007/s10787-022-00928-w PMC 바로가기 [Article Type] Randomized Controlled Trial
Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records전자 건강 기록을 사용한 COVID-19 mRNA 백신 3회 접종의 안전성 감시Article Published on 2022-04-012022-09-12 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI addition Administered Adverse adverse event adverse events age analyzed anaphylaxis approval arthralgia BNT162b2 booster vaccination booster vaccinations chill clinical trials Cohort cohort study cohorts comparable conducted control groups COVID-19 COVID-19 mRNA vaccine COVID-19 mRNA vaccines criteria diarrhea dose drug EHR eligible evaluate fatigue Fever food headache Health increased risk individual individuals Mayo Clinic median mRNA mRNA vaccine mRNA-1273 myalgia myocarditis nausea outcome participant profile quantified receiving recent Record regimen remained reported Reporting risk Safety SARS-COV-2 infection second dose severe adverse event study inclusion study participant thrombosis vaccination Vaccine vaccine dose Vaccine-induced immunity venous vomiting was tested were assessed [DOI] 10.1001/jamanetworkopen.2022.7038 PMC 바로가기 [Article Type] Article
Effects of Iranian Polyherbal Syrup (Zufa syrup) on oxygen saturation and clinical symptoms in suspected patients with COVID-19: a triple-blinded, randomized, placebo-controlled trialRandomized Controlled Trial Published on 2022-04-012022-10-05 Journal: Medical gas research [Category] COVID19(2023년), SARS, 임상, [키워드] age anorexia Anxiety approval approved Arm ARMS bypassing caused center Chest computed tomography clinical clinical symptom Combination Cordia Corona Coronavirus disease 2019 COVID-19 dose Dyspnea Effect Efficacy eligibility criteria Ethics ethics committee Evidence Fennel Follow-up headache herbal drug Hospital admission in both groups Insomnia Iran IRIS male Mild moderate myalgia Nepetabracteata no difference offer oxygen saturation pandemic Papaver participant Patient Placebo placebo-controlled trial plant potential treatments Pulse rate Qom Randomized Randomized controlled trial receive recruited reference number Registered required Respiratory disease respiratory infections Science severity of symptoms study period sugar Supplemental oxygen therapy suspected patient symptoms of COVID-19 syrup Traditional Traditional medicine Treatment Trial triple-blind university Viola VIPER were assessed [DOI] 10.4103/2045-9912.325991 PMC 바로가기 [Article Type] Randomized Controlled Trial